XTNT — Xtant Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- $123.71m
- $139.96m
- $91.30m
- 30
- 62
- 51
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 64.7 | 53.3 | 55.3 | 58 | 91.3 |
Cost of Revenue | |||||
Gross Profit | 42.5 | 34.4 | 32.5 | 32.1 | 55.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 67 | 54.1 | 59.1 | 64.7 | 89.8 |
Operating Profit | -2.35 | -0.751 | -3.85 | -6.75 | 1.54 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.12 | -6.73 | -4.85 | -8.42 | -1.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.22 | -7.02 | -4.85 | -8.48 | 0.66 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.22 | -7.02 | -4.85 | -8.48 | 0.66 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.22 | -7.02 | -4.85 | -8.48 | 0.66 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.62 | -0.246 | -0.057 | -0.09 | -0.055 |